Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease - a pilot study

Circulation Journal

Volumn 72, Issue 10, 2008, Pages 1583-1587

  Huang, Shih Ming ^a,b,e   Weng, Ken Pen ^a,c,e   Chang, Jeng Sheng ^d   Lee, Wei Yang ^b   Huang, Shih Hui ^e   Hsieh, Kai Sheng ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG MUNICIPAL UNITED HOSPITAL   (Taiwan)

^c ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e FOOYIN UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chronic vascular inflammation; Endothelial dysfunction; Flow mediated dilation; High sensitivity C reactive protein; Kawasaki disease

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BRACHIAL ARTERY; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ANOMALY; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; SEX DIFFERENCE;

ADOLESCENT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CORONARY VESSEL ANOMALIES; HOSPITALS, VETERANS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUCOCUTANEOUS LYMPH NODE SYNDROME; TAIWAN; TRIGLYCERIDES;

EID: 52749097905     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0121     Document Type: Article

References (31)

1. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: Implications for premature atherosclerosis. J Am Coll Cardiol 2004; 43: 120-124.
2. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS): With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 1986; 36: 1513-1527.
3. Sugimura T, Kato H, Inoue O, Fukuda T, Sato N, Ishii M, et al. Intravascular ultrasound of coronary arteries in children: Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994; 89: 258-265.
4. Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004; 90: 1281-1285.
5. Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 2005; 26: 782-786.
6. Suzuki A, Yamagishi M, Kimura K, Sugiyama H, Arakaki Y, Kamiya T, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol 1996; 27: 291-298.
7. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
8. Rodenburg J, Vissers MN, Wiegman A, Trip MD, Bakker HD, Kastelein JJ. Familial hypercholesterolemia in children. Curr Opin Lipidol 2004; 15: 405-411.
9. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial dependent flow mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
10. Weng KP, Hsieh KS, Huang SH, Lin CC, Huang DC. Serum HDL level at acute stage of Kawasaki disease. Acta Paediatr Sin 1998; 39: 28-32.
11. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991; 84: 625-631.
12. Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 2003; 22: 34-39.
13. McCrindle BW, Mcintyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr 2007; 151: 244-248.
14. Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr 2008; 167: 189-196.
15. Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005; 111: 38-43.
16. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
17. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriguez JA, et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: Implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006; 47: 1369-1378.
18. Jialal I, Devaraj S, Singh U. C-reactive protein and the vascular endothelium: Implications for plaque instability. J Am Coll Cardiol 2006; 47: 1379-1381.
19. Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 2003; 22: 34-39.
20. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, et al. Endothelial dysfunction late after Kawasaki disease. Circulation 1996; 94: 2103-2106.
21. Liu XQ, Huang GY, Liang XC, Tao ZY, Chen WD, Lin QS. The study of vascular lesion using ultrasound in children with a history of Kawasaki disease. Zhonghua Yi Xue Za Zhi 2007; 87: 2117-2120.
22. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: A case-control study. J Pediatr 2001; 138: 400-405.
23. Ii M, Losordo DW. Statins and the endothelium. Vasc Pharmacol 2007; 46: 1-9.
24. Ehrenstein MR, Jury EC, Mauri C. Statins for atherosclerosis: As good as it gets? N Engl J Med 2005; 352: 73-75.
25. Masumoto A, Hirooka Y, Hironaga K, Eshima K, Setoguchi S, Egashira K, et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin). Am J Cardiol 2001; 88: 1291-1294.
26. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-471.
27. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.
28. de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 2002; 40: 2117-2121.
29. Pozza RD, Bechtold S, Urschel S, Kozlik-Feldmann R, Netz H. Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. J Pediatr 2007; 151: 239-243.
30. Arambepola C, Farmer AJ, Perera R, Neil HA. Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis. Atherosclerosis 2007; 195: 339-347.
31. Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, et al. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2007; 27: 1803-1810.